Patient-Reported Outcomes with Roflumilast Foam 0.3% in Patients with Psoriasis of the Scalp and Body in the Phase 3 ARRECTOR Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 2, p. s525, 2025. DOI: 10.25251/skin.10.supp.525. Disponível em: https://skin.dermsquared.com/skin/article/view/3265. Acesso em: 30 apr. 2026.